Coloplast AS (OCSE:COLO B) Net Change in Cash : kr-150 Mil (TTM As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Coloplast AS's Net Change in Cash for the three months ended in Mar. 2025 was kr-177 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was kr-150 Mil.

Coloplast AS Net Change in Cash Historical Data

The historical data trend for Coloplast AS's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Net Change in Cash Chart

Coloplast AS Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Net Change in Cash

Get a 7-Day Free Trial

1.00

103.00

-69.00

534.00

-88.00

Coloplast AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-27.00	-6.00	-85.00	118.00	-177.00

Coloplast AS Net Change in Cash Calculation

Coloplast AS's Net Change in Cash for the fiscal year that ended in Sep. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	2766	+	-1336	+	-1518	+	0
	=	-88

Coloplast AS's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 742 + -309 + -598 + -12

= -177

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-150 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Coloplast AS's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Net Change in Cash

Comparable Companies

OCSE:DEMANT OCSE:AMBU B OCSE:EMBLA OCSE:GN OCSE:CHEMM OCSE:SMSMED OCSE:VIRO ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 XPAR:DIM XSWX:STMN COO BAX WST NZSE:FPH

Traded in Other Exchanges

CLPBY:USA CLPBF:USA 0QBO:Mexico COLOBc:UK 0QBO:UK CBHD:Germany COLO:Austria

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines